Complete Treatment Comparison Without Price Surprises
Can I Change From Wegovy to Mounjaro? Understanding Your Treatment Options
When patients ask "can I change from Wegovy to Mounjaro", the question reflects the importance of finding the right weight management approach for individual circumstances. Both prescription-only medicines work through different mechanisms - Wegovy contains semaglutide, a GLP-1 receptor agonist, whilst Mounjaro contains tirzepatide, which targets both GIP and GLP-1 receptors as a dual agonist. This fundamental difference means some patients may respond differently to each treatment alongside their reduced-calorie diet and increased physical activity. The decision to switch should always involve your prescriber, who can assess your progress, side effect profile, and individual medical history.
At EverydayMeds, we've eliminated the pricing confusion that plagues many online pharmacies when patients want to explore treatment options. Our transparent approach means you'll never encounter surprise consultation fees, hidden prescription charges, or unexpected admin costs that other providers often add at checkout. When you're considering whether you can change from Wegovy to Mounjaro, you deserve complete clarity about both the clinical differences and the total cost involved. This transparency allows you to focus on the medical decision rather than worrying about budget surprises that could affect your long-term treatment commitment.
Complete Pricing Transparency for Wegovy and Treatment Switches
Understanding the true cost when you're wondering "can I change from Wegovy to Mounjaro" requires knowing exactly what you'll pay without hidden extras. Our Wegovy pricing structure includes everything: 0.25mg starter dose at £79.99, 0.5mg at £94.99, 1mg at £99.99, 1.7mg at £139.99, and 2.4mg maintenance dose at £209.99. These prices include your clinical assessment, prescriber review, prescription fee, and next-day cold-chain delivery - no separate charges that mysteriously appear during checkout. For patients considering treatment transitions, our Getting Started Bundles provide dose progression support, such as the Intro Duo (0.25mg & 0.5mg) for £169.99 or the Progress Duo (0.5mg & 1mg) for £189.99.
New customers benefit from our FIRST40 discount code applied at checkout, whilst returning customers use DOSE25 - both codes are already factored into the prices shown above. This approach contrasts sharply with competitors who advertise low medication prices but then add consultation fees of £30-60, prescription charges, and delivery costs that can double your total spend. When evaluating whether you can change from Wegovy to Mounjaro, our transparent pricing extends to both treatments, ensuring you can make informed decisions based on clinical suitability rather than hidden cost concerns that emerge later in the process.
Clinical Evidence Supporting Treatment Decisions
The decision of whether you can change from Wegovy to Mounjaro should be informed by robust clinical evidence from major trials. Wegovy's efficacy is demonstrated through the STEP trial programme, where patients taking semaglutide alongside diet and exercise achieved average weight reductions of approximately 15% at 68 weeks in STEP 1 (Wilding et al., NEJM, 2021). The STEP 2 trial showed that patients with type 2 diabetes experienced average weight reductions of around 9.6%, whilst STEP 3 demonstrated approximately 16% average reduction when combined with intensive behavioural therapy.
For patients considering treatment switches, it's important to understand that both medications work differently and clinical responses may vary between individuals. The recent SELECT cardiovascular outcomes trial showed a 20% reduction in major cardiovascular events with semaglutide treatment, providing additional clinical context for long-term treatment decisions. These trial results provide the evidence base that prescribers use when helping patients determine whether switching treatments aligns with their individual health goals and medical circumstances.
How Wegovy Works - GLP-1 Mechanism Explained
Understanding how Wegovy functions helps patients considering whether they can change from Wegovy to Mounjaro appreciate the different mechanisms involved. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics glucagon-like peptide-1, a natural hormone produced in your intestines when you eat. This hormone targets receptors in your brain that control appetite and food intake, potentially reducing hunger signals and promoting feelings of fullness after smaller meals. The medication may also slow gastric emptying, meaning food stays in your stomach longer, contributing to extended satiety between meals. Additionally, Wegovy may help reduce food cravings by working on appetite control centres in the brain, though individual responses can vary. This GLP-1-only mechanism differs from dual-agonist approaches like tirzepatide, which explains why some patients may respond differently to each treatment option.
Streamlined Ordering Process for Treatment Transitions
When patients decide they can change from Wegovy to Mounjaro, or wish to start Wegovy treatment, our ordering process eliminates the complexity found with many online pharmacies. The journey begins with a comprehensive 3-minute clinical assessment that covers your medical history, current medications, and treatment goals - this detailed evaluation is included in your medication price, not charged separately. Your completed assessment then undergoes review by our qualified prescribers, with standard processing taking 3 working days or express 24-hour service for urgent requirements. Once approved, your prescription-only medicine ships via next-day delivery using cold-chain temperature-controlled packaging to maintain medication integrity. Our GPhC-registered pharmacy (#9012878) ensures full regulatory compliance throughout the process. Finally, you'll receive tracking information and storage guidance, with ongoing support available for any questions about your treatment - all included in your transparent pricing structure.
Storage and Practical Considerations for Treatment Switches
Patients asking "can I change from Wegovy to Mounjaro" should understand the practical differences that might influence their decision beyond clinical considerations. Wegovy requires refrigerated storage between 2-8°C before first use, but offers significant travel convenience with up to 6 weeks of room temperature storage below 30°C once removed from the fridge. The medication comes in Novo Nordisk's FlexTouch pre-filled pen format, designed for once-weekly subcutaneous injection with dose escalation from 0.25mg through to the 2.4mg maintenance dose over 16 weeks. This gradual dose increase cannot be skipped, as it allows your body to adjust to the medication and helps minimise potential side effects. The storage advantage compared to some alternatives - Wegovy's 6 weeks versus Mounjaro's 21 days at room temperature - can be particularly relevant for patients who travel frequently or have variable refrigeration access. These practical factors, whilst secondary to clinical effectiveness, often play important roles in long-term treatment adherence and patient satisfaction.
Why Complete Price Transparency Matters for Treatment Switches
The question "can I change from Wegovy to Mounjaro" often arises when patients encounter unexpected costs that make their current treatment financially unsustainable. Many online pharmacies advertise attractive headline prices, then add consultation fees ranging from £30-60, prescription charges of £10-20, and delivery costs that can increase your total spend by 50-100%. This pricing structure creates particular challenges for patients considering treatment switches, as they cannot accurately compare total costs or budget for ongoing treatment. Our transparent approach means the price you see includes everything required for your treatment journey.
When evaluating whether you can change from Wegovy to Mounjaro, complete cost transparency becomes even more critical as you're comparing two different treatments with potentially different dosing schedules and price structures. Hidden fees can distort this comparison and lead to decisions based on incomplete financial information rather than clinical suitability. Our commitment to pricing clarity extends across both treatment options, ensuring that your choice between Wegovy and Mounjaro reflects genuine clinical preference and prescriber guidance rather than confusion about true treatment costs that only become apparent after commitment.
Start Your Transparent Treatment Journey Today
Whether you're wondering "can I change from Wegovy to Mounjaro" or beginning your weight management journey, our transparent approach eliminates the pricing uncertainty that affects many patients' treatment decisions. New customers can use discount code FIRST40 at checkout, whilst returning customers benefit from DOSE25 - both codes help achieve the inclusive prices shown throughout our range. Our comprehensive service includes clinical assessment, prescriber review, prescription processing, and cold-chain delivery, with no hidden extras that appear unexpectedly during checkout. The combination of clinical expertise from our qualified prescribers and complete pricing transparency provides the foundation for informed treatment decisions. Both Wegovy and Mounjaro are available through our GPhC-registered service, allowing your prescriber to determine which option best suits your individual circumstances and medical history. Visit our Wegovy collection to begin your assessment and experience the difference that complete pricing transparency makes to your treatment journey.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
